This Week in Addiction Medicine from ASAM

This Week in Addiction Medicine from ASAM

Por: American Society of Addiction Medicine





This Week in Addiction Medicine is an audio summary of the recent top stories and research articles from the field of addiction medicine. Intended to serve as an accompaniment to the ASAM Weekly newsletter or as a stand-alone resource, This Week covers recent publications in addiction medicine research.













100 episodios disponibles

Latest episodes of the podcast This Week in Addiction Medicine from ASAM

Lead: State Laws Banning Prior Authorization For Medications For Opioid Use Disorder Increased Substantially, 2015–23 18/11/2025
Lead: Rapid vs Standard Induction to Injectable Extended-Release Buprenorphine 11/11/2025
Lead: States With Substantial Increases In Buprenorphine Uptake Did So With Increased Medicaid Prescribing, 2018–24 04/11/2025
Lead: Ultra-processed food addiction in a nationally representative sample of older adults in the USA 28/10/2025
Lead: Alcohol Consumption Per Capita and Suicide: A Meta-Analysis 21/10/2025
Lead: Measures of General Intelligence and Risk for Alcohol Use Disorder 14/10/2025
Lead: Medications for Opioid Use Disorder Playbook 10/10/2025
Lead: Cannabis Use During Pregnancy and Lactation 30/09/2025
Lead: Contingency Management for Stimulant Use Disorder and Association With Mortality: A Cohort Study 23/09/2025
Lead: Machine learning– and multilayer molecular network–assisted screening hunts fentanyl compound 16/09/2025
Lead: Evaluation of a Novel Patient-Centered Methadone Restart Protocol 09/09/2025
Lead: Recommendations for Addressing In-Hospital Substance Use From a National Delphi Consensus Process 02/09/2025
Lead: Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting 26/08/2025
Lead: Association between housing status and mental health and substance use severity among individuals with opioid use disorder and co-occurring depression and/or PTSD 19/08/2025
Lead: Oral methadone versus sublingual buprenorphine for the treatment of acute opioid withdrawal: A triple-blind, double-dummy, randomized control trial 12/08/2025
Lead: Implementation Gaps in US Syringe Service Programs, 2022 05/08/2025
Lead: Co-involvement of stimulants with opioids in North America: A 'silent epidemic’ 29/07/2025
Lead: Did alcohol facilitate the evolution of complex societies? 22/07/2025
Lead: Disparities in Treatment and Referral After an Opioid Overdose Among Emergency Department Patients 15/07/2025
Lead: Prescriber-Level Changes in Buprenorphine Dispensing in the USA Before and After Federal Policy Changes Aimed at Increasing Prescribing 08/07/2025
1 2 3 ... 5 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA